Cite
[Genetic risk after high dose radioiodine therapy with regard to gonadal dose].
MLA
Ehrenheim, C., et al. “[Genetic Risk after High Dose Radioiodine Therapy with Regard to Gonadal Dose].” Nuklearmedizin. Nuclear Medicine, vol. 36, no. 5, Aug. 1997, pp. 157–66. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9380527&authtype=sso&custid=ns315887.
APA
Ehrenheim, C., Hauswirth, C., Fitschen, J., Martin, E., Oetting, G., & Hundeshagen, H. (1997). [Genetic risk after high dose radioiodine therapy with regard to gonadal dose]. Nuklearmedizin. Nuclear Medicine, 36(5), 157–166.
Chicago
Ehrenheim, C, C Hauswirth, J Fitschen, E Martin, G Oetting, and H Hundeshagen. 1997. “[Genetic Risk after High Dose Radioiodine Therapy with Regard to Gonadal Dose].” Nuklearmedizin. Nuclear Medicine 36 (5): 157–66. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9380527&authtype=sso&custid=ns315887.